Following the Community Input Meetings in San Francisco and Los Angeles in October and November of 2017, the Executive Committee of the policy centers—consisting of investigators from the academic and community partners at both centers, as well as CHRP project officers—met to review the priority areas, identify commonalities and overlap, consider feasibility, and map out […]
PrEP is a highly effective medication for preventing HIV. Those interested in PrEP and enrolling in a Covered California health plan should carefully weigh the costs of a Truvada® prescription, copays for regular doctors’ visits and laboratory tests, and monthly premiums. With Gilead’s copay card, PrEP is affordable (less than $400/year) on all Covered California […]
PrEP is a highly effective medication for preventing HIV. Those interested in PrEP and enrolling in a Covered California health plan should carefully weigh the costs of a Truvada® prescription, copays for regular doctors’ visits and laboratory tests, and monthly premiums. With Gilead’s copay card, PrEP is affordable (less than $400/year) on all Covered California […]
Young gay, bisexual, and other men who have sex with men (YMSM), particularly black and Latino YMSM, are at highest risk for HIV in California and across the United States. The Centers for Disease Control and Prevention estimates that if current rates persist, half of all black—and a quarter of all Latino—gay and bisexual men […]
The Centers for Disease Control and Prevention (CDC) estimates that 156,300 (95% CI 144,100–165,900) Americans living with HIV in 2012 were unaware of their infection. To increase knowledge of HIV status, CDC guidelines seek to make HIV screening a routine part of medical care. This paper examines how routinely California primary care providers test for […]
We sought to identify people living with HIV/AIDS from Medicare and Medicaid claims data to estimate Medicaid costs for treating HIV/AIDS in California. We also examined how alternate methods of identifying the relevant sample affect estimates of per capita costs. We analyzed data on Californians enrolled in Medicaid with an HIV/AIDS diagnosis reported in 2007 […]
The HIV/AIDS community is currently talking about “ending the AIDS epidemic” or “achieving an AIDS-free generation.” This conversation–optimistic, speculative, and sometimes controversial–focuses on three evidence-based HIV prevention interventions: Treatment as Prevention (TasP), Post-Exposure Prophylaxis (PEP), and Pre-Exposure Prophylaxis (PrEP). All three interventions utilize existing anti-retroviral medications to reduce transmission of HIV and prevent new infections […]
In 2011, the California State Office of AIDS (OA) launched the Office of AIDS Health Insurance Premium Payment Program (OA-HIPP) to assist HIV-positive Californians in establishing and maintaining health insurance by subsidizing their monthly health insurance premium payments. The OA reformulated an existing premium payment program with more restricted eligibility requirements (the Comprehensive AIDS Resources […]
In preparation for full Affordable Care Act implementation, California has instituted two healthcare initiatives that provide comprehensive coverage for previously uninsured or underinsured individuals. For many people living with HIV, this has required transition either from the HIV-specific coverage of the Ryan White program to the more comprehensive coverage provided by the county-run Low-Income Health […]
Historically, California supplemented federal funding of HIV prevention and testing so that Californians with HIV could become aware of their infection and obtain lifesaving treatment. However, budget deficits in 2009 led the state to eliminate its supplemental funding for HIV prevention. We analyzed the impact of California’s HIV resource allocation change between state fiscal years […]
